CIK 0001724521 · Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473898435
- Phone
- (510) 694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Option exercise 10b5-1 | +2,827 | $15.44 | $44K | 42,408 |
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Sale 10b5-1 | −2,827 | $30.00 | $85K | 39,581 |
| 2026-08-21 | Azoy Alexander Chief Accounting Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −2,827 | 3,073 | ||
| 2026-07-10 | Jaen Juan C. President | Sale 10b5-1 | −19,799 | $28.61 | $566K | 822,508 |
| 2026-07-10 | Jaen Juan C. President | Sale 10b5-1 | −268 | $29.40 | $8K | 822,240 |
| 2026-07-09 | Jaen Juan C. President | Sale 10b5-1 | −48,502 | $30.05 | $1.5M | 842,307 |
| 2026-06-24 | Jaen Juan C. President | Sale 10b5-1 | −6,431 | $29.66 | $191K | 890,809 |
| 2026-06-23 | Jaen Juan C. President | Sale 10b5-1 | −14,067 | $27.69 | $389K | 898,937 |
| 2026-06-23 | Jaen Juan C. President | Sale 10b5-1 | −1,697 | $28.06 | $48K | 897,240 |
| 2026-06-22 | Jaen Juan C. President | Sale 10b5-1 | −9,236 | $27.03 | $250K | 913,004 |
| 2026-06-11 | Tang Carolyn C. General Counsel | Option exercise | +34,090 | $2.57 | $88K | 184,607 |
| 2026-06-11 | Tang Carolyn C. General Counsel | Option exercise · Stock Option (Right to Buy) | −34,090 | $2.57 | $88K | 0 |
| 2026-06-11 | Ribas Antoni Director | Grant or award | +5,700 | 44,300 | ||
| 2026-06-11 | Ribas Antoni Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-11 | Lambert Nicole Director | Grant or award | +5,700 | 43,000 | ||
| 2026-06-11 | Lambert Nicole Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-11 | Lacey David L. Director | Grant or award | +5,700 | 76,652 | ||
| 2026-06-11 | Lacey David L. Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 | ||
| 2026-06-11 | Machado Patrick Director | Grant or award | +5,700 | 44,300 | ||
| 2026-06-11 | Machado Patrick Director | Grant or award · Stock Option (Right to Buy) | +16,900 | 16,900 |
Page 1 of 9 · 177 trades